Suven Life Sciences Limited

Web: suven.com NSE: SUVEN BSE: 530239 SECTOR: Healthcare - Healthcare Services

317 2(-1%)

Volume

16L as on 23, Jun

Open

132

High

138

Low

131

319

VWAP

263

52 Week High

371

52 Week Low

124

Viand Research Rating

Quality Score

0/100

Growth Score

10/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

8,369

No. of Shares

26.4

P/E

-104.53

P/B

3.29

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

-3.15

ROCE

Profit Growth

Listing Date

23-Oct-03

Promoter Holding

70.15%

FII Holding

0.91%

DII Holding

4.62%

Price Chart

Price Performance

1 Week4%

1 Month3%

3 Months104%

6 Months79%

1 Year79%

YTD79%

Moving Average

5 Day SMA263

10 Day SMA265

20 Day SMA265

30 Day SMA258

50 Day SMA238

61 Day SMA222

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	288	269	283	286
Resistance 2	283	268	277	282
Resistance 1	274	266	274	272
Pivot Point	268	265	268	268
Support 1	260	264	263	258
Support 2	254	262	260	253
Support 3	246	261	254	244

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,099	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,792	7300	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,70,907	5050	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,264	8851	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,12,694	1395	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,623	1109	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,686	2399	3%	3%	11%	25%	23	57.7	0.29	5355
8	MANKIND	1,05,603	2557	0%	0%	18%	3%	49	57.7	0.39	1938
9	MAXHEALTH	1,05,114	1080	2%	1%	8%	14%	0	57.7	0.32	1442
10	DRREDDY	97,638	1170	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jul 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(2.81) 70.15%	(0.01) 67.36%	(-0.11) 67.36%	(-2.81) 67.42%	(0.01) 70.26%	(0.01) 70.26%	(0.01) 70.26%	(0.01) 70.26%	(0.71) 70.26%	(0.01) 69.56%	(0.01) 69.56%	(0.01) 69.56%	(0.01) 69.56%	(0.01) 69.56%	(4.61) 69.56%	(0.01) 64.98%	(0.01) 64.98%	(5.01) 64.98%	(0.01) 60.00%	(0.01) 60.00%
FIIs	(-0.21) 0.91%	(-0.11) 1.07%	(0.61) 1.17%	(0.01) 0.56%	(0.31) 0.58%	(-0.11) 0.25%	(0.01) 0.34%	(-0.11) 0.33%	(0.01) 0.45%	(-0.11) 0.46%	(0.01) 0.54%	(0.01) 0.50%	(0.01) 0.48%	(0.11) 0.51%	(0.01) 0.46%	(0.01) 0.48%	(0.01) 0.45%	(-0.11) 0.45%	(0.11) 0.52%	(0.01) 0.44%
DIIs	(1.21) 4.62%	(0.01) 3.39%	(0.01) 3.39%	(3.41) 3.41%	(0.01) 0.03%	(-1.01) 0.01%	(0.01) 1.05%	(0.01) 1.05%	(0.01) 1.05%	(1.01) 1.05%	(0.01) 0.01%	(-0.11) 0.01%	(0.01) 0.08%	(0.01) 0.11%	(0.01) 0.11%	(-0.31) 0.12%	(-0.11) 0.39%	(0.01) 0.46%	(0.01) 0.44%	(0.01) 0.44%
Public	24.32%	28.18%	28.07%	28.61%	29.12%	29.47%	28.35%	28.34%	28.21%	28.91%	29.88%	29.92%	29.88%	29.80%	29.85%	34.41%	34.18%	34.11%	39.04%	39.12%
No. of Shareholders	63,915	64,381	64,921	65,574	66,159	64,603	63,537	63,975	66,116	68,959	74,003	80,953	76,291	78,634	80,838	80,116	81,038	81,039	80,195	81,475

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	2	3	1	2	1	2	3	1	2	2	3	4	3	3	4	4	4	4	1	2
Sales Growth % (YoY)	3.4%	74.5%	-64.2%	85.2%	-38.5%	-34.3%	-16%	-73.4%	-8.4%	-18.3%	-30.3%	7.3%	-38.2%	-32%	272%	76%	170.5%	193.4%	-86.9%	41%
Sales Growth % (QoQ)	-33.3%	200%	-50%	100%	-50%	-33.3%	200%	-50%	-	-33.3%	-25%	33.3%	-	-25%	-	-	-	300%	-50%	-
Expenses	52	106	81	53	45	41	55	32	33	49	27	32	34	55	26	25	24	37	29	45
Operating Profit	-51	-103	-80	-51	-44	-39	-52	-31	-30	-46	-24	-28	-32	-52	-22	-21	-20	-32	-28	-43
OPM %	-3331	-3678	-8671	-2714	-2981	-2435	-2032	-3024	-1267	-1885	-768	-737	-1208	-1719	-494	-596	-467	-733	-2340	-2118
Other Income	7	3	4	1	1	2	4	4	4	6	13	6	6	2	0	6	0	0	0	5
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	2	1	1	1	1	2	1	1	2	2	2	2	2	2	2	2	1	1	1	1
Profit before tax	-46	-102	-77	-52	-44	-39	-50	-28	-28	-42	-13	-24	-28	-51	-23	-16	-21	-34	-28	-39
Tax %	0	0	0	0	0	0	0	0	-4	0	0	0	0	0	0	0	0	0	0	0
Net Profit	-46	-102	-77	-52	-44	-39	-50	-28	-27	-42	-13	-24	-28	-51	-23	-16	-21	-34	-28	-39
Net Profit Growth % (QoQ)	54.9%	-32.5%	-48.1%	-18.2%	-12.8%	22%	-78.6%	-3.7%	35.7%	-223.1%	45.8%	14.3%	45.1%	-121.7%	-43.8%	23.8%	38.2%	-21.4%	28.2%	-
Net Profit Growth % (YoY)	-4.5%	-161.5%	-54%	-85.7%	-63%	7.1%	-284.6%	-16.7%	3.6%	17.6%	43.5%	-50%	-33.3%	-50%	17.9%	59%	-	-	-	-
TTM Net Profit	-277	-275	-212	-185	-161	-144	-147	-110	-106	-107	-116	-126	-118	-111	-94	-99	-122	-101	-67	0
EPS in Rs	-1.73	-4.48	-3.4	-2.36	-2.01	-1.79	-2.28	-1.29	-1.22	-1.91	-0.58	-1.1	-1.27	-2.34	-1.06	-0.75	-0.95	-1.76	-1.48	-2.05

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2008	Mar 2007
Sales	7	7	12	14	12	13	13	286	625	543	499	521	117	112
Sales Growth %	6.8%	-43%	-13.7%	14.4%	-12.2%	6.8%	-95.6%	-54.3%	15.1%	8.8%	-4.1%	-	4.8%	27%
Expenses	292	172	140	139	134	93	128	300	427	414	398	361	105	96
Operating Profit	-284	-166	-128	-126	-122	-80	-116	-14	198	129	102	159	13	16
OPM %	-4001	-2487	-1094	-929	-1032	-593	-917	-5	32	24	20	31	11	15
Other Income	14	11	29	14	5	8	14	27	23	21	19	9	3	1
Interest	0	0	0	0	1	1	1	2	5	6	6	5	5	3
Depreciation	6	6	6	7	4	4	4	11	21	21	18	12	4	4
Profit before tax	-276	-161	-106	-118	-122	-77	-106	0	196	123	98	152	6	11
Tax %	0	0	-1	0	0	-7	-11	15038	37	29	26	28	-32	-5
Net Profit	-276	-161	-105	-118	-122	-72	-94	-24	124	87	72	109	8	11
Net Profit Growth %	-71.4%	-53.3%	11%	3.3%	-69.4%	23.4%	-291.7%	-119.4%	42.5%	20.8%	-33.9%	1262.5%	-27.3%	-
EPS in Rs	-10.48	-7.37	-4.82	-5.42	-5.59	-3.78	-4.94	-1.25	6.48	4.57	3.76	5.7	0.48	0.65
Dividend Payout %	0	0	0	0	0	0	0	-80	15	15	35	7	35	26

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2008	Mar 2007
Cash from Operating Activity	-302	-154	-115	-116	-128	-96	-135	-53	70	109	68	143	4	16
Cash from Investing Activity	-462	155	94	-248	-22	56	146	30	-1	-311	-39	-110	-16	-20
Cash from Financing Activity	757	-1	-1	396	146	35	3	5	-52	-30	-68	179	6	13
Net Cash Flow	-7	0	-22	32	-4	-5	14	-18	17	-232	-39	212	-7	8

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2008	Mar 2007
Equity Capital	26	23	22	22	22	22	15	13	13	13	13	13	13	13	12	6
Reserves	565	259	88	171	248	354	82	95	131	226	755	654	583	547	95	96
Borrowings	17	0	0	0	1	2	3	5	6	3	34	71	83	109	55	41
Other Liabilities	16	56	25	19	14	12	9	16	33	62	118	78	74	105	38	30
Total Liabilities	624	337	135	212	285	389	108	128	182	303	919	816	751	773	199	173
Fixed Assets	73	58	60	25	28	37	38	21	25	22	308	306	305	172	110	96
CWIP	4	1	0	0	0	0	4	5	0	0	25	10	7	107	4	5
Investments	181	247	22	74	76	46	45	0	0	223	279	301	0	0	2	5
Other Assets	367	32	53	113	181	305	22	103	157	58	308	199	439	494	83	68
Total Assets	624	337	135	212	285	389	108	128	182	303	919	816	751	773	199	173

Delivery

#	Date	202 83% 371	Value (Cr)	Q/T 64	Del 31	Del 28
1	22-Jul	319	28	46	40	11
2	21-Jul	340	18	40	36	6
3	20-Jul	338	38	46	32	12
4	17-Jul	326	36	49	37	14
5	16-Jul	341	36	40	33	12
6	15-Jul	356	25	48	27	7
7	14-Jul	348	27	49	41	11
8	13-Jul	360	46	55	35	16
9	10-Jul	358	126	59	29	36
10	9-Jul	347	101	68	36	36
11	8-Jul	317	46	63	28	13
12	7-Jul	319	52	53	30	16
13	6-Jul	314	47	67	39	18
14	3-Jul	328	347	83	15	52
15	2-Jul	298	121	74	31	38
16	1-Jul	274	13	57	44	6
17	30-Jun	281	26	52	32	8
18	29-Jun	277	77	64	26	20
19	25-Jun	267	56	70	33	19
20	24-Jun	255	18	55	38	7
21	23-Jun	258	41	57	41	17
22	22-Jun	265	41	61	37	15
23	19-Jun	268	39	58	42	17
24	18-Jun	260	24	50	38	9
25	17-Jun	263	94	60	27	26
26	16-Jun	270	61	41	27	16
27	15-Jun	270	20	58	41	8
28	12-Jun	268	28	53	28	8
29	11-Jun	263	22	55	35	8
30	10-Jun	269	42	57	19	8
31	9-Jun	264	109	66	15	16
32	8-Jun	234	32	51	32	10
33	5-Jun	237	74	58	33	24
34	4-Jun	266	81	59	26	21
35	3-Jun	275	28	64	43	12
36	2-Jun	275	77	73	52	40
37	1-Jun	275	49	64	54	26
38	29-May	279	65	57	37	24
39	27-May	267	21	45	37	8
40	26-May	274	80	59	26	21
41	25-May	271	23	47	30	7
42	22-May	265	21	47	32	7
43	21-May	270	32	58	20	6
44	20-May	269	83	66	15	12
45	19-May	269	434	71	7	32
46	18-May	253	416	89	11	47
47	15-May	211	11	40	37	4
48	14-May	207	8	41	52	4

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	8,369c	0	0
22-Jul	8,369c	634c	7.04
21-Jul	9,002c	436c	5.08
17-Jul	8,567c	436c	4.84
16-Jul	9,002c	349c	3.73
15-Jul	9,351c	186c	2.03
14-Jul	9,165c	397c	4.16
13-Jul	9,562c	140c	1.44
10-Jul	9,702c	462c	5.00
09-Jul	9,240c	822c	9.77
08-Jul	8,417c	26c	0.31
07-Jul	8,444c	128c	1.54
06-Jul	8,316c	457c	5.81
02-Jul	7,859c	450c	6.07
30-Jun	7,409c	32c	0.43
29-Jun	7,378c	324c	4.60
26-Jun	7,053c	13c	0.19
25-Jun	7,040c	324c	4.83
24-Jun	6,716c	98c	1.43
23-Jun	6,813c	132c	1.90
22-Jun	6,945c	112c	1.59
19-Jun	7,057c	214c	3.12
18-Jun	6,844c	145c	2.08
17-Jun	6,989c	156c	2.18
16-Jun	7,144c	19c	0.26
15-Jun	7,126c	21c	0.30
12-Jun	7,147c	193c	2.77
11-Jun	6,954c	115c	1.62
10-Jun	7,069c	0	0

Stock Checklist

Price is above from 52 week high low average: 56%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: YES

Mutual Fund Holdings

Held by 6 fund scheme(s) across 3 fund house(s) as of Jul26 · Total value ₹199 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
quant Mutual Fund	2	0.33%	-	199.2
Bandhan Mutual Fund	2	0.10%	-	0
Motilal Oswal Mutual Fund	2	0.01%	-	0

Suven Life Sciences Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements